Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics DifferentlyNazar Farid, Daniel E. Salazar, Christopher D. Payne et al.|Clinical Pharmacology & Therapeutics|2007Cited by 323
Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementationM. Urooj Zafar, Juan J. Badimón, Juan F. Viles-González et al.|Journal of Thrombosis and Haemostasis|2012Cited by 59
Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjectsNazar Farid, D. S. Small, Joseph A. Jakubowski et al.|Current Medical Research and Opinion|2009Cited by 34
Switching to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjectsJoseph A. Jakubowski, Kenneth J. Winters, Christopher D. Payne et al.|Cardiovascular revascularization medicine|2007Cited by 0
A 60-mg loading dose of prasugrel achieves greater platelet inhibition than 300-mg and 600-mg loading doses of clopidogrelJoseph A. Jakubowski, Kenneth J. Winters, Christopher D. Payne et al.|Cardiovascular revascularization medicine|2007Cited by 0